Category: Guidelines
New Study: The Impact of the COVID-19 Health Crisis on Access to HIV Services in Egypt, Morocco, Mauritania, and Tunisia.
A study was carried out by the FORSS consortium which includes (ITPC-MENA, Solidarité SIDA, AGD, ATP+, Al Shehab RdR Maroc, and M-Coalition). This recently developed report analyzes the impact of the COVID-19 pandemic on HIV-related health services in the MENA...
Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!
Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first line ARVs? GNP+ invites you to...
A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt
The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which is currently taking place in Paris...
BLOG: We want dolutegravir for all, and we want it now
Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to be...
ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV CARE: FOCUS ON HIV TESTING
Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with low coverage of ART, standing at 14% of...
New WHO Guidance Report- Treatment Failure and Drug Resistance
WHO urges action against HIV drug resistance threat 20 JULY 2017 | GENEVA - WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns...
The HepC Pill Bill
Source : hepCoalition The HepC Pill Bill-An insight into the availability, pricing and accessibility of HCV treatment Introduction to Direct Acting Antivirals Hepatitis C treatment has remarkably evolved over the years. The previously known standard HCV regimen consisted of a...
Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medicines Workshop
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The...
WHO Launches New HIV Treatment and Prevention Guidelines
The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. The recommendations in this...
The first Middle East and North Africa Community Advisory Board (MENA-CAB)
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases...